Fulcrum Therapeutics
Erin Valentine is a Senior Scientist II at Fulcrum Therapeutics since April 2017, specializing in early discovery within the Neuroscience group, focusing on neuroinflammation targets. Prior experience includes roles as a Senior Scientist at Fulcrum Therapeutics and a Cell Scientist at ORIG3N. Erin Valentine also spent over a decade at Merck, starting as a Research Scientist and later serving as a Research Biologist, contributing to drug discovery projects for cancer targets. Early in the career, Erin Valentine worked as a Research Associate at Minerva Biotechnologies. Educational qualifications include a Master of Science in Biotechnology & Biomedical Sciences from UMass Boston, obtained in 2006.